By Yantoultra Ngui and Anshuman Daga SINGAPORE (Reuters) – Chinese healthcare and biotech firms are ripe for consolidation due to a sharp decline in valuations after the COVID-19 pandemic spurred …
Tag:
By Yantoultra Ngui and Anshuman Daga SINGAPORE (Reuters) – Chinese healthcare and biotech firms are ripe for consolidation due to a sharp decline in valuations after the COVID-19 pandemic spurred …